Boston Scientific Corporation Securities Litigation
Boston Scientific Corporation
Boston Scientific shareholders allege the company made misleading statements that artificially inflated its stock price during a two-month window in 2020. When the truth emerged, the stock dropped, causing investor losses. Eligible investors may receive a pro rata share of the settlement fund.
Who may qualify
You qualify if you purchased or otherwise acquired Boston Scientific common stock between September 16, 2020 and November 16, 2020, inclusive, and suffered damages as a result.
How to claim
This claim is publicly available and free to file yourself directly with the settlement administrator. Read the official eligibility rules and deadline before filing - they are the source of truth. PendingMoney can find, fill, and track it for you, but you can always do it on your own.
View official requirements on bostonscientificsecuritieslitigation.comNot sure if this one - or others - may be waiting in your name? Run a free 2-minute check.
Find My Pending MoneyEligibility and payouts are not guaranteed and are decided by the settlement administrator, not PendingMoney. PendingMoney is not a law firm and does not provide legal advice. Available to U.S. residents only.